Share this article
Shutterstock Scaled

Autoimmune Association Statement on CMS Decision to Delay Copay Assistance Rule

Washington, D.C. (Tuesday, December 22, 2020) — Autoimmune patients welcome the Administration’s decision to delay implementation of the Medicaid best price rule that would jeopardize critically important copay assistance programs. The two-year delay highlights the flawed nature of this harmful policy. While the action is a step in the right direction, Autoimmune Association remains deeply concerned that the proposed change could eventually be implemented.  Instead, this provision should be withdrawn.

In a survey earlier this year, Autoimmune Association found that 92 percent or more of autoimmune patients report that copay assistance helps them afford medicines and take them as prescribed. Reducing copay assistance programs potentially threatens patient health and well-being by unfairly shifting the burden of cost away from insurers and PBMs and onto patients, who are often struggling to manage costs of care.

Earlier this year, Autoimmune Association strongly opposed an equally harmful policy that will permit insurers and PBMs to exclude the value of copay program cost-sharing assistance when calculating a patient’s deductibles and out-of-pocket maximum requirements. Unlike the rule that was just delayed, this rule governing insurance practices could affect patients in the New Year, and a follow-along proposed rulemaking for 2022 further calls into question support for copay assistance support to patients longer-term. Collectively, the Administration’s delayed rule, and those slated for immediate implementation by insurers and in 2022, represent a threat to the ability of patients to access their medicines and take them as prescribed, even as they and their families struggle with negative implications of the COVID-19 pandemic.

Autoimmune Association continues to advocate for patients’ access to care, and we urge policymakers and regulators do the same. Patients deserve better. Autoimmune Association strongly encourages the new Administration and the new Congress to support copay assistance and put patients’ health and wellness first.

 

# # #

Contact: Brett McReynolds; 615-594-0145; [email protected]

Share this article

Join our email list

Receive the latest blog articles, news, and more right to your inbox!

  • Categories

  • Archives

Related articles you might be interested in

Autoimmune Association Image Do Not Touch

Autoimmune Association Advocates for Federal Legislation to Reform Harmful PBM Practices

What are Pharmacy Benefit Managers (PBMs)? Pharmacy Benefit Managers, or PBMs, are entities that handle prescription drug benefits for health insurance plans. They...
Autoimmune Association Image Do Not Touch

5 Promising Areas in Autoimmune Research

In a recent discussion at the Autoimmune Community Summit, Nina Luning Prak, MD, PhD, chair of the Autoimmune Association’s Medical and Scientific Advisory...
Autoimmune Association Image Do Not Touch

Raising Hope: Andy Capmany

Welcome to our inspiring blog series, Raising Hope, where we feature stories of individuals who are making a difference for the autoimmune community...
Autoimmune Association Image Do Not Touch

Erika Page: Finding Purpose in Connection and Community

Erika Page is a fun-loving, compassionate mom of two. She also lives with vitiligo. And although she struggled significantly with the changes in...

Find more resources on autoimmunity

Learn more about autoimmunity, diagnosis tips, how to find a physician, and more.